Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 19(3)2018 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-29534036

RESUMO

(1) Objective: Highlight the in vitro effects of 3T3-L1 cell exposure to polychlorinated biphenyls (PCB118 and 153) or benzo(a)pyrene (BaP) alone or as a cocktail on adipogenesis (ADG) by focusing on changes in lipid metabolism and inflammatory-related genes expression (INFG) and ADG-related genes expression (ADGG); (2) Results: Treatment from the early stage of cell differentiation by BaP alone or in combination with PCBs decreased the expression of some of the ADGG (PPARγGlut-4, FAS, Lipin-1a, Leptin, and Adiponectin). BaP enhanced the INFG, especially MCP-1 and TNFα. Co-exposure to BaP and PCB153 showed a synergistic effect on TNFα and IL6 expression. Treatment with BaP and PCBs during only the maturation period up-regulated the INFG (IL6, TNFα, CXCL-10 & MCP-1). PCB118 alone also enhanced TNFα, CXCL-10, and PAI-1 expression. The change in MCP-1 protein expression was in agreement with that of the gene. Finally, the BaP-induced up-regulation of the xenobiotic responsive element (XRE)-controlled luciferase activity was impaired by PCB153 but not by PCB118; (3) Conclusion: BaP and PCBs down-regulate a part of ADGG and enhance INFG. The direct regulatory effect of PCBs on both ADGG and INFG is usually rather lower than that of BaP and synergistic or antagonistic cocktail effects are clearly observed.


Assuntos
Adipogenia/efeitos dos fármacos , Benzo(a)pireno/farmacologia , Citocinas/metabolismo , Poluentes Ambientais/farmacologia , Bifenilos Policlorados/farmacologia , Células 3T3 , Animais , Citocinas/genética , Regulação para Baixo , Antagonismo de Drogas , Sinergismo Farmacológico , Transportador de Glucose Tipo 4/genética , Transportador de Glucose Tipo 4/metabolismo , Inflamação/metabolismo , Leptina/genética , Leptina/metabolismo , Camundongos , PPAR gama/genética , PPAR gama/metabolismo , Elementos de Resposta
2.
Eur J Cell Biol ; 86(3): 143-60, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17275949

RESUMO

Mn(2+) was found to induce adhesion of HT29-D4 adenoma carcinoma cells to fibrinogen (Fb). This was independent of the expression of the beta3 integrin subunit and involved endogenous alphavbeta6 but not alphavbeta5 integrin. Thus, addition of Mn(2+) led to a change in integrin alphavbeta6 specificity. Furthermore, Mn(2+) was found to strongly activate the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathway in the HT29-D4 cell line. As a MAPK inhibitor strongly reduced the Mn(2+)-induced cell adhesion to Fb, it is suggested that a link between MAPK activation and cell adhesion to Fb exists. Both expression and activity of matrix metalloproteinase-9 (MMP-9) were enhanced by Mn(2+) and this led to Fb processing. MMP inhibitors prevented Mn(2+)-mediated cell adhesion to Fb, leading us to suggest that Mn(2+) promoted convergent changes in integrin alphavbeta6 conformation and Fb structure through activation of ERK/MAPK and MMP-9. Finally, we found that Mn(2+) and activators of the ERK pathway cooperated in HT29-D4 cell adhesion to Fb. Such a process may be involved in bone metastasis of some cancer cells.


Assuntos
Antígenos de Neoplasias/metabolismo , Fibrinogênio/metabolismo , Integrinas/metabolismo , Manganês/farmacologia , Metaloproteinase 9 da Matriz/metabolismo , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Ativação Enzimática/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Fibronectinas/metabolismo , Substâncias de Crescimento/farmacologia , Células HT29 , Humanos , Integrina alfaVbeta3/metabolismo , Magnésio/farmacologia , Metaloproteinase 9 da Matriz/genética , Oligopeptídeos/farmacologia , Proteína Quinase C/metabolismo , Receptores de Vitronectina/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , Regulação para Cima/efeitos dos fármacos , Vitronectina/metabolismo
3.
Biochem Biophys Res Commun ; 305(4): 831-9, 2003 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-12767906

RESUMO

Pretreatment of HT29-D4 epithelial adenocarcinoma colic cells with des-IGF-1 upregulated TNF alpha-mediated activation of IL-8 expression at different levels (protein, mRNA, and hnRNA). RNA transcription but not RNA stabilization was found to be involved. In this cell line, cooperation of NF-kappa B with other factors appeared essential for IL-8 expression. Indeed, TNF alpha-induced NF-kappa B translocation was not sufficient to support enhancement of the transcription and des-IGF-1 did not promote but partly inhibited both the TNF alpha-induced NF-kappa B activation and I kappa B alpha degradation through a PI-3K-dependent pathway. A CCAAT/enhancer binding protein (C/EBP) site located on the IL-8 gene enhancer cooperated with a NF-kappa B binding site and led to the upregulation of IL-8 expression. Binding of C/EBP alpha to this sequence disappeared in IGF-1 treated cells. This event may be important for the cross-talk between IGF-1- and TNF alpha-mediated pathways leading to the control of inflammatory processes and the decision concerning apoptosis or cell survival.


Assuntos
Fator de Crescimento Insulin-Like I/farmacologia , Interleucina-8/genética , NF-kappa B/metabolismo , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/farmacologia , Adenocarcinoma , Amanitinas/farmacologia , Sítios de Ligação , Proteína alfa Estimuladora de Ligação a CCAAT/metabolismo , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Neoplasias do Colo , Regulação para Baixo , Humanos , Proteínas I-kappa B/metabolismo , Interleucina-8/biossíntese , Cinética , Inibidor de NF-kappaB alfa , Fragmentos de Peptídeos/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , RNA Mensageiro/biossíntese , Fator de Transcrição AP-1/fisiologia , Ativação Transcricional , Células Tumorais Cultivadas , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...